FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine and discloses use of a composition containing tingenin A, tingenin B and celastrol or pharmaceutically acceptable salts thereof for treating or preventing vitiligo. Also disclosed is the use of a composition containing tingenin A, tingenin B and celastrol or pharmaceutically acceptable salts thereof for inhibiting matrix metalloproteinase-9 (MMP-9).
EFFECT: providing an effective therapy with no side effects with strong anti-inflammatory and higher antioxidant activity.
12 cl, 6 tbl, 1 dwg, 3 ex
